Showing 1 - 4 results of 4 for search 'Chi-Lam Au Yeung', query time: 0.02s
Refine Results
-
1
ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression by Tsz-Lun Yeung, Ching Chou Tsai, Cecilia S. Leung, Chi-Lam Au Yeung, Melissa S. Thompson, Karen H. Lu, Ralph S. Freedman, Michael J. Birrer, Kwong-Kwok Wong, Samuel C. Mok
Published 2018-11-01
Article -
2
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression by Suet-Ying Kwan, Chi-Lam Au-Yeung, Tsz-Lun Yeung, Angela Rynne-Vidal, Kwong-Kwok Wong, John I. Risinger, Hui-Kuan Lin, Rosemarie E. Schmandt, Melinda S. Yates, Samuel C. Mok, Karen H. Lu
Published 2020-01-01
Article -
3
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype by Wen Hu, Li Zhang, Sammy Ferri-Borgogno, Suet-Ying Kwan, Kelsey E. Lewis, Han T. Cun, Tsz-Lun Yeung, Pamela T. Soliman, Rohinton S. Tarapore, Joshua E. Allen, Xinyuan Guan, Karen H. Lu, Samuel C. Mok, Chi-Lam Au-Yeung
Published 2020-08-01
Article -
4
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. <i>Cancers</i> 2020, <i>12</i>, 2436 by Wen Hu, Li Zhang, Sammy Ferri-Borgogno, Suet-Ying Kwan, Kelsey E. Lewis, Han T. Cun, Tsz-Lun Yeung, Pamela T. Soliman, Rohinton S. Tarapore, Joshua E. Allen, Xinyuan Guan, Karen H. Lu, Samuel C. Mok, Chi-Lam Au-Yeung
Published 2021-02-01
Article